Genentech, Biogen say cancer drug helps against MS
(Re
Reuters - Biotechnology companies Genentech Inc.
and Biogen Idec Inc. on Monday said their cancer drug Rituxan
showed hints of effectiveness against multiple sclerosis in a
small mid-stage trial.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace